About BGES
Bio-Bridge Science, Inc. operates as a biotechnology company. It focuses on the commercial development of HIV-PV Vaccine I, HPV vaccine, colon cancer vaccine, mucosal adjuvant and the manufacture and sale of vaccine production-related materials. The company was founded by Wenhui Qiao, Liang Qiao, Shyh-Jing Chiang and Isao Arimoto on October 26, 2004 and is headquartered in Oakbrook Terrace, IL.